Results 191 to 200 of about 168,609 (264)

Cardiac structure and function recovery in acromegaly after treatment: insights from cardiac magnetic resonance imaging. [PDF]

Front Endocrinol (Lausanne)
Chen Y, Li Y, Tang Y, Li J, Yu Y, Tan H, Cai B, Jiang S, Wang W, Zheng S, Zhou P, Wei Y, Sun J, Chen Y, Li J.   +14 more
europepmc   +1 more source

Evaluation of 12-lead electrocardiogram at 0.55T for improved cardiac monitoring in magnetic resonance imaging

Aravindan Kolandaivelu, Christopher G. Bruce, Felicia Seemann, Dursun Korel Yildirim, Adrienne Campbell‐Washburn, Robert J. Lederman, Daniel A. Herzka   +6 more
openalex   +1 more source

Indices of diastolic function assessed by cardiac magnetic resonance cine imaging in domestic pigs under rest and β-adrenergic stress

, 2015
Gabriel Adelsmayr, Gert Reiter, Heiner Post, Alessio Alogna, Martin Manninger-Wünscher, Michael Fuchsjäger, Ursula Reiter   +6 more
openalex   +1 more source

Predictors of prognosis by cardiac magnetic resonance imaging in patients with idiopathic restrictive heart disease. [PDF]

Egypt Heart J
Asfour AS, Mohamed AMAA, Al-Salam HYA, Aboelsoud HMA, Shaaban M, Elramly MZ.   +5 more
europepmc   +1 more source

Photon-counting detector computed tomography compared with cardiac magnetic resonance imaging for myocardial extracellular volume quantification in spontaneous coronary artery dissection. [PDF]

Sci Rep
Klambauer K, Biondo A, Klotz E, Moser LJ, Demmert T, Schweiger V, Mergen V, Würdinger M, Di Vece D, Gotschy A, Reiner MF, Ghadri JR, Wilzeck VC, Eberhard M, Templin C, Manka R, Alkadhi H.   +16 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Cardiac magnetic resonance imaging in the assessment of cardiac injury and toxicity from cancer-related chemotherapy. [PDF]

Pediatr Radiol
Johnson JN, Berthod TL, Cai X, Campbell MJ, Dodeja AK, Goode CG, Hor KN, Jacobs HM, Lee S, Loke YH, Lorenzoni RP, Morin CE, Popescu AR, Soslow JH, Trask ER, Toro-Salazar OH.   +15 more
europepmc   +1 more source

Reduced native T₁ on cardiac magnetic resonance imaging as a novel marker of myocardial involvement in Niemann-Pick disease type B. [PDF]

Am Heart J Plus
Redzepi B, Antiochos P, Tran C, Barbosa JV, Masi A, Zhang M, Adheriyani R, Campos-Xavier B, Schwitter J.   +8 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source